The FDA outlines draft guidance on AI for medical devices
The agency also published draft guidance on the use of AI in drug development
Read more...During the bubble years -- 1999-2000 - it wasn't uncommon for napkin ideas to get funded. In 1999, 250 venture-backed companies went public. So, it was surprising to see that despite all the easy-money circumstances back in the Kool-Aid-inebriated years, only 38% of the 4,757 companies that received venture funding went out of business. One would think it would be more like 90%. But perhaps it's just the case that people only like to share the good news, but not the bad.
In other stats released about the bubble years, in 1999-2000, about 2.7%, or 128, out of 4,757 VC-funded companies went public, according to Dow Jones' research unit, VentureOne. Last year, 416 VC-backed companies were acquired, while 56 went public.
Founder and CEO of Vator, a media and research firm for entrepreneurs and investors; Managing Director of Vator Health Fund; Co-Founder of Invent Health; Author and award-winning journalist.
All author postsThe agency also published draft guidance on the use of AI in drug development
Read more...The biggest focus areas for AI investing are healthcare and biotech
Read more...It will complete and submit forms, and integrate with state benefit systems
Read more...